Skip to main content
Premium Trial:

Request an Annual Quote

The Worst Stem Cell of All

New York Times reports on a project set to kick off in the next few months in which three medical research centers -- the University of Michigan Comprehensive Cancer Center, Dana-Farber Cancer Institute, and Baylor College of Medicine -- will begin testing patients for the presence of cancerous stem cells to see if there's hope for therapeutically targeting them in the future. According to the article, detractors say that the theory of cancerous stem cells has yet to be proven and is not backed by scientific evidence.

 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.